Related Experiment Video
Updated: Jul 15, 2026
08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Quantification and identification of soluble HLA-G isoforms.
V Rebmann1, J LeMaoult, N Rouas-Freiss
1Institute of Immunology, University Hospital of Essen, Essen, Germany.
Tissue Antigens
|April 21, 2007
Summary
This study validated enzyme-linked immunosorbent assay (ELISA) methods for quantifying soluble human leukocyte antigen-G (sHLA-G) molecules. The validated assays reliably detect sHLA-G in body fluids, confirming their presence in healthy donors.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Soluble human leukocyte antigen-G (sHLA-G) molecules play a role in immune regulation.
- Reliable quantification methods are needed to understand the diagnostic relevance of sHLA-G.
Purpose of the Study:
- To select and validate HLA-G-specific ELISA formats for measuring sHLA-G.
- To establish standardized protocols and reference standards for sHLA-G quantification.
Main Methods:
- A workshop involving 13 international laboratories was conducted.
- Two ELISA formats were validated: one for sHLA-G1 + sHLA-G5 and one for sHLA-G5.
- Purified HLA-G5 protein was used as a standard reference.
Main Results:
- Both validated ELISA formats specifically and reproducibly quantified sHLA-G molecules.
- The HLA-G5 standard was detected equally by both ELISA formats, enabling result comparison.
- Evidence for a novel soluble HLA-G structure was observed.
Conclusions:
- Validated ELISA methods allow for reliable quantification of sHLA-G molecules.
- sHLA-G1 and sHLA-G5 molecules are present in the blood of healthy individuals.
- Further research into novel soluble HLA-G structures is warranted.
